Journal article
Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study
Abstract
PURPOSE: Adalimumab (ADA) is a tumor necrosis factor-α inhibitor indicated for use in various immune-mediated inflammatory diseases. Patients receiving ADA in Canada are eligible to enroll in the AbbVie Care's Patient Support Program (PSP), which provides personalized services, including tailored interventions in the form of nurse-provided care coach calls (CCCs), with the goal of improving patients' experiences and outcomes. The primary …
Authors
Marshall JK; Bessette L; Thorne C; Shear NH; Lebovic G; Gerega SK; Millson B; Oraichi D; Gaetano T; Gazel S
Journal
Clinical Therapeutics, Vol. 40, No. 3, pp. 415–429.e6
Publisher
Elsevier
Publication Date
March 2018
DOI
10.1016/j.clinthera.2018.02.001
ISSN
0149-2918